Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MMP2 antisense RNA 1 (MMP2-AS1) is a long non-coding RNA (lncRNA) that is transcribed from the opposite DNA strand of the MMP2 gene. It is referenced in genomic databases as ENST00000569037 and LOC105371279. There is no evidence that MMP2-AS1 codes for a protein or acts as a therapeutic target, receptor, enzyme, transporter, or similar molecule. Its function is not fully established in the literature, and it is primarily classified as a genetic element of interest due to its antisense relationship to the MMP2 gene. No interacting drugs, validated mechanisms of action, biomarker roles, or specific safety concerns have been reported in the current literature or major databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MMP2 antisense RNA 1 (MMP2-AS1).